MDMSCF, I was reading a post earlier today where the poster mentioned that some of the early Phase III trial patients were from the Ukraine and that they have had many drop out of the trial. If this is true, how would that affect your modeling? Thank you. Member mark was from me.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.